Risk factors

Tecogen updated its risk profile after listing on the NYSE American stock exchange and reporting a net loss of $8,248,755 for 2025. Backlog dropped to $2,522,231 from $12,336,248, and goodwill declined to $1,248,442.

Terra Property Trust faces liquidity pressures regarding 2026 notes and heightened geographic and property concentrations in its loan portfolio.

California-centric real estate and water asset risks dominate the risk profile.

Taysha advanced its lead gene therapy TSHA-102 into pivotal trials, losing emerging growth company status and increasing compliance burdens.

Tigo Energy added new risks focusing on U.S. regulatory changes like the IRA and OBBB, domestic content rules, and foreign entity of concern compliance.

UAMY expanded its risk disclosures around trade policy, foreign supplier dependencies, joint venture management, and equity investments in Larvotto Resources.

Company updates trade tariff risks following USITC actions and expands application markets for its graphite products.

Risk section changes are minimal, featuring only a reworded disclosure on Nasdaq listing requirements for risk 31.

Clinical trials for ZB Assets face risks from prior trial translation and trial design changes in the TibuSHIELD study. International trade policies and new tariffs create supply chain and operational uncertainties. An internal audit subcommittee review regarding BAFFX17 and Stone Peach adds potential financial and reputational risks.

The company removed its going concern and net loss warnings but disclosed it has only one covering analyst.

Company is a blank check entity targeting international businesses in the APAC and MENA regions for valuation arbitrage. Risks are dominated by SPAC structure mechanics, potential redemptions, extension rights, and lack of target visibility.

Accelerant Holdings' risk profile centers on managing its Risk Exchange, maintaining partner capital relationships, and avoiding underwriting losses in specialty insurance.